BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38046560)

  • 21. X-linked agammaglobulinemia. A clinical and molecular analysis.
    Ochs HD; Smith CI
    Medicine (Baltimore); 1996 Nov; 75(6):287-99. PubMed ID: 8982147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of BTK mutations in male Algerian patterns with agammaglobulinemia and severe B cell lymphopenia.
    Boushaki S; Tahiat A; Meddour Y; Chan KW; Chaib S; Benhalla N; Smati L; Bensenouci A; Lau YL; Magdinier F; Djidjik R
    Clin Immunol; 2015 Dec; 161(2):286-90. PubMed ID: 26387629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of Bruton's agammaglobulinemia tyrosine kinase gene, BTK, is selectively down-regulated in T lymphocytes and plasma cells.
    Smith CI; Baskin B; Humire-Greiff P; Zhou JN; Olsson PG; Maniar HS; Kjellén P; Lambris JD; Christensson B; Hammarström L
    J Immunol; 1994 Jan; 152(2):557-65. PubMed ID: 8283037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bruton's tyrosine kinase expression and activity in X-linked agammaglobulinaemia (XLA): the use of protein analysis as a diagnostic indicator of XLA.
    Gaspar HB; Lester T; Levinsky RJ; Kinnon C
    Clin Exp Immunol; 1998 Feb; 111(2):334-8. PubMed ID: 9486400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of Bruton's tyrosine kinase (Btk) gene mutations and characterization of the derived proteins in 35 X-linked agammaglobulinemia families: a nationwide study of Btk deficiency in Japan.
    Hashimoto S; Tsukada S; Matsushita M; Miyawaki T; Niida Y; Yachie A; Kobayashi S; Iwata T; Hayakawa H; Matsuoka H; Tsuge I; Yamadori T; Kunikata T; Arai S; Yoshizaki K; Taniguchi N; Kishimoto T
    Blood; 1996 Jul; 88(2):561-73. PubMed ID: 8695804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel deletion mutation in Bruton's tyrosine kinase results in X-linked agammaglobulinemia: A case report.
    Hu XM; Yuan K; Chen H; Chen C; Fang YL; Zhu JF; Liang L; Wang CL
    World J Clin Cases; 2020 Sep; 8(17):3859-3866. PubMed ID: 32953865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel Bruton's tyrosine kinase gene (BTK) invariant splice site mutation in a Malaysian family with X-linked agammaglobulinemia.
    Chear CT; Gill HK; Ramly NH; Dhaliwal JS; Bujang N; Ripen AM; Mohamad SB
    Asian Pac J Allergy Immunol; 2013 Dec; 31(4):320-4. PubMed ID: 24383975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel BTK gene mutation creates a de-novo splice site in an X-linked agammaglobulinemia patient.
    Chear CT; Ripen AM; Mohamed SA; Dhaliwal JS
    Gene; 2015 Apr; 560(2):245-8. PubMed ID: 25680287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of Bruton's tyrosine kinase mutations in Mexican patients with X-linked agammaglobulinemia.
    Lopez-Herrera G; Berron-Ruiz L; Mogica-Martinez D; Espinosa-Rosales F; Santos-Argumedo L
    Mol Immunol; 2008 Feb; 45(4):1094-8. PubMed ID: 17765309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel deletion mutation and structural abnormality in the Bruton's tyrosine kinase gene identified in a Chinese patient with X-linked agammaglobulinemia.
    Wang S; Lu Y; Li H; Wang Z; Mo X; Chai Z; Han J
    Clin Lab; 2014; 60(5):859-62. PubMed ID: 24839832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. X-Linked Agammagobulinemia in a Large Series of North African Patients: Frequency, Clinical Features and Novel BTK Mutations.
    Aadam Z; Kechout N; Barakat A; Chan KW; Ben-Ali M; Ben-Mustapha I; Zidi F; Ailal F; Attal N; Doudou F; Abbadi MC; Kaddache C; Smati L; Touri N; Chemli J; Gargah T; Brini I; Bakhchane A; Charoute H; Jeddane L; El Atiqi S; El Hafidi N; Hida M; Saile R; Alj HS; Boukari R; Bejaoui M; Najib J; Barbouche MR; Lau YL; Mellouli F; Bousfiha AA
    J Clin Immunol; 2016 Apr; 36(3):187-94. PubMed ID: 26931785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Bruton's tyrosine kinase gene is expressed throughout B cell differentiation, from early precursor B cell stages preceding immunoglobulin gene rearrangement up to mature B cell stages.
    de Weers M; Verschuren MC; Kraakman ME; Mensink RG; Schuurman RK; van Dongen JJ; Hendriks RW
    Eur J Immunol; 1993 Dec; 23(12):3109-14. PubMed ID: 8258324
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutation analysis of the Bruton's tyrosine kinase gene in X-linked agammaglobulinemia: identification of a mutation which affects the same codon as is altered in immunodeficient xid mice.
    de Weers M; Mensink RG; Kraakman ME; Schuurman RK; Hendriks RW
    Hum Mol Genet; 1994 Jan; 3(1):161-6. PubMed ID: 8162018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Gene diagnosis of X-linked agammaglobulinemia].
    Wang XC; Wang Y; Kanegane H; Toshio M; Yu YH
    Zhonghua Er Ke Za Zhi; 2005 Jun; 43(6):449-52. PubMed ID: 16053733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bruton tyrosine kinase (BTK) in X-linked agammaglobulinemia (XLA).
    Vihinen M; Mattsson PT; Smith CI
    Front Biosci; 2000 Dec; 5():D917-28. PubMed ID: 11102316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atypical X-linked agammaglobulinaemia caused by a novel BTK mutation in a selective immunoglobulin M deficiency patient.
    Lim LM; Chang JM; Wang IF; Chang WC; Hwang DY; Chen HC
    BMC Pediatr; 2013 Sep; 13():150. PubMed ID: 24074005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Composition of precursor B-cell compartment in bone marrow from patients with X-linked agammaglobulinemia compared with healthy children.
    Noordzij JG; de Bruin-Versteeg S; Comans-Bitter WM; Hartwig NG; Hendriks RW; de Groot R; van Dongen JJ
    Pediatr Res; 2002 Feb; 51(2):159-68. PubMed ID: 11809909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of Btk mutations in patients with X-linked agammaglobulinaemia (XLA) and determination of carrier status in normal female relatives: a nationwide study of Btk deficiency in Greece.
    Speletas M; Kanariou M; Kanakoudi-Tsakalidou F; Papadopoulou-Alataki E; Arvanitidis K; Pardali E; Constantopoulos A; Kartalis G; Vihinen M; Sideras P; Ritis K
    Scand J Immunol; 2001 Sep; 54(3):321-7. PubMed ID: 11555397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new mutation that predicted a drastic alteration of the BTK protein function.
    Debost-Legrand A; Legrand G; Moulillot G; Francannet C; Bocly B; Theodoroub I; Paillard C
    Gene; 2013 Sep; 527(1):426-8. PubMed ID: 23774691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel mutation (Cys145-->Stop) in Bruton's tyrosine kinase is associated with newly diagnosed X-linked agammaglobulinemia in a 51-year-old male.
    Kornfeld SJ; Haire RN; Strong SJ; Tang H; Sung SS; Fu SM; Litman GW
    Mol Med; 1996 Sep; 2(5):619-23. PubMed ID: 8898377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.